Publikationen von U. Reichl
Alle Typen
Konferenzbeitrag (36)
301.
Konferenzbeitrag
Proteomic analysis of influenza A virus infected mammalian cells by 2D-DIGE. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, S. 429 - 432 (Hg. Noll, T.). 20th ESACT Meeting, Dresden, Germany, 17. Juni 2007 - 20. Juni 2007. (2010)
302.
Konferenzbeitrag
Metabolic flux distribution during growth of adherent growing MDCK cells in different media. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, S. 459 - 462 (Hg. Noll, T.). 20th ESACT Meeting, 2007-06-17, 20. Juni 2007. (2010)
303.
Konferenzbeitrag
25, S. 133 - 138 (Hg. Braunschweig, B.; Joulia, X.). 18th European Symposium on Computer Aided Process Engineering - ESCAPE, Lyon, France, 01. Juni 2008 - 04. Juni 2008. (2008)
Population balance modeling of influenza virus replication in MDCK cells during vaccine production. In: 18th European Symposium on Computer Aided Process Engineering: ESCAPE 18, Bd. 304.
Konferenzbeitrag
Closed loop control of perfusion systems in high-density cell culture. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, S. 549 - 551 (Hg. Smith, R.). 19th ESACT Meeting, Harrogate, UK, 05. Juni 2005 - 08. Juni 2005. Springer, Dordrecht, The Netherlands (2007)
305.
Konferenzbeitrag
Serum-free influenza vaccine production with MDCK cells in wave-bioreactor and 5L-stirred tank bioreactor. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, S. 563 - 565 (Hg. Smith, R.). 19th ESACT Meeting , Harrogate, UK, 05. Juni 2005 - 08. Juni 2005. Springer, Dordrecht, The Netherlands (2007)
306.
Konferenzbeitrag
Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, S. 503 - 508 (Hg. Smith, R.). 19th ESACT Meeting, Harrogate, UK, 05. Juni 2005 - 08. Juni 2005. Springer, Dordrecht, The Netherlands (2007)
307.
Konferenzbeitrag
Cultivation of E-FL in Perfusion Mode Using Wave Bioreactor and Stirre-Tank Reactor for Parvovirus Vaccine Production. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, S. 519 - 522 (Hg. Smith, R.). 19th ESACT Meeting, Harrogate, UK, 05. Juni 2005 - 08. Juni 2005. Springer, Dordrecht, The Netherlands (2007)
308.
Konferenzbeitrag
Strategies for Large Scale Production of Parapoxvirus Ovis NZ-2. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, S. 707 - 710 (Hg. Smith, R.). 19th ESACT Meeting, Harrogate, UK, 05. Juni 2005 - 06. August 2005. Springer, Dordrecht, The Netherlands (2007)
309.
Konferenzbeitrag
7, S. 191 - 208. Ringberg-Symposium, Kreuth, Germany, 03. Mai 2006 - 05. Mai 2006. (2007)
Biological Fundamentals, Models and Technologies for Vaccine Production. In: Perspectives of Research - Identification and Implementation of Research Topics by Organizations: Ringberg-Symposium Mai 2006, Bd. 310.
Konferenzbeitrag
Monitoring of Cell Physiology in Influenza Vaccine Production by Flow Cytometry. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, S. 531 - 533 (Hg. Smith, R.). 19th ESACT Meeting, Harrogate, UK, 05. Juni 2005 - 06. August 2005. Springer, Dordrecht, The Netherlands (2007)
311.
Konferenzbeitrag
Glutamine-free media for vaccine production processes. In: Animal Cell Technology meets Genomics: Proceedings ot the 18th ESACT Meeting, S. 767 - 770 (Hg. Godia, F.; Fussenegger, M.). 18th ESACT Meeting , Granada, Spain, 11. Mai 2003 - 14. Mai 2003. (2005)
312.
Konferenzbeitrag
Serum free cultivation of primary chicken embryo fibroblasts in microcarrier systems for vaccine production. In: Animal Cell Technology Meets Genomics: Proceedings of the 18th ESACT Meeting, S. 771 - 774. 18th ESACT Meeting, Granada, Spain, 11. Mai 2003 - 14. Mai 2003. (2005)
313.
Konferenzbeitrag
Animal cell cultures for the production of viral vaccines. In: GVC/DECHEMA Vortrags- und Diskussiontagung "Zellkulturen: vom biologischen System zum Produktionsprozess", S. 32 - 35. GVC/DECHEMA : Vortrags- und Diskussionstagung, Bad Dürkheim, Deutschland, 26. Mai 2003 - 28. Mai 2003. (2003)
314.
Konferenzbeitrag
Development of bioprocess concepts on vaccine production: influenza virus as an example. In: Animal cell technology: from target to market, S. 344 - 346 (Hg. Lindner-Olsson, E.; Chatzissavidou, N.; Luellau, E.). 17th ESACT Meeting, Tylösand, Sweden, 10. Juni 2001 - 14. Juni 2001. (2001)
315.
Konferenzbeitrag
ISCOMs - Antigen production and downstream processing. In: Proceedings of the 4th International Congress on Biochemical Engineering, S. 314 - 318 (Hg. Brunner, H.). International Congress on Biochemical Engineering; 4, Stuttgart, Germany, 17. Februar 2000 - 18. Februar 2000. Fraunhofer-IRB-Verlag, Stuttgart (2000)
316.
Konferenzbeitrag
Investigations of pellet forming microorganisms by means of an image processing system. In: 5th European Congress on Biotechnology: Vol. 2, S. 1166 - 1170 (Hg. Christiansen, C.; Munck, L.; Villadsen, J.). 5th European Congress on Biotechnology, Copenhagen, Denmark, 08. Juli 1990 - 13. Juli 1990. Munksgaard, Copenhagen (1990)
317.
Konferenzbeitrag
Early growth of Streptomyces in submerged culture. In: 8th DECHEMA annual meeting of biotechnologists, S. 825 - 828 (Hg. Behrens, D.; Krämer, P.). 8th DECHEMA annual meeting of biotechnologists, Frankfurt am Main, Germany, 28. Mai 1990 - 30. Mai 1990. VCH, Weinheim (1990)
318.
Konferenzbeitrag
3A (Hg. Behrens, D.). 7. Jahrestagung der Biotechnologen, Frankfurt am Main, Germany, 01. Juni 1989 - 02. Juni 1989. VCH, Weinheim (1989)
Use of an image processing system for investigation of the morphology of filamentously growing microorganisms. In: 7th DECHEMA annual meeting of biotechnologists, Bd. Meeting Abstract (45)
319.
Meeting Abstract
53 (2) Special Issue: SI Aufl., P376. Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), Strasbourg (France), 26. September 2023. Wiley-VCH, Weinheim (2023)
Adjuvanted SARS-CoV-2 spike protein vaccination with altered glycosylation elicits improved TH1 humoral and cellular immunity in mice. In European Journal of Immunology, 320.
Meeting Abstract
Producing viruses in orbit: Current developments for orbital shaken viral vaccine manufacturing. In Proceedings Vaccine Technology VIII, 54. Vaccine Technology VIII, Sitges (Spain), 12. Juni 2022 - 17. Juni 2022. (2022)